Mapi Pharma Ltd.

Mapi Pharma signed a long-term lease at Har-Hotzvim Hi-Tech Park in Jerusalem for a new sterile production plant for GA Depot injectable products. The ~50,000 sq ft facility was previously an FDA-approved facility of Omrix Biopharmaceuticals. Investment in equipment is approximately $13 million, partially funded by a $2.5 million grant.